The present invention relates to the treatment of coronary heart disease by revascularization therapy, and more particularly to the intramyocardial injection of a pharmaceutical composition comprising a recombinant fibroblast growth factor-1 protein or a fragment of a recombinant fibroblast growth factor-1...http://www.google.es/patents/US7252818?utm_source=gb-gplus-sharePatente US7252818 - Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
Method of producing biologically active human acidic fibroblast growth ...
